Literature DB >> 18393365

Identification of the Alzheimer's disease amyloid precursor protein (APP) and its homologue APLP2 as essential modulators of glucose and insulin homeostasis and growth.

B E Needham1, M E Wlodek, G D Ciccotosto, B C Fam, C L Masters, J Proietto, S Andrikopoulos, R Cappai.   

Abstract

The amyloid precursor protein (APP), the source of the neurotoxic amyloid beta (A beta) peptide involved in Alzheimer's disease (AD), belongs to a conserved family of related proteins. In mammals, the APP family contains amyloid precursor-like protein 1 (APLP1) and amyloid precursor-like protein 2 (APLP2). Whilst a number of activities have been attributed to the APP family, an overall function has not been definitively established. While ablating either the APP or APLP2 gene in mice produces minimal phenotypic change, the combined knockout of these genes in mice causes postnatal mortality. Postnatal survival therefore requires a shared but unknown function of APP and APLP2. To investigate the biochemical basis for the postnatal lethality, plasma was analysed from double knockout mice (APP-/- APLP2-/-) 2 days before birth, at gestational day E17, and from mice at 12-16 h after birth. The postnatal double knockouts had 66% lower plasma glucose levels than their wild-type controls and 50% lower than their single knockout counterparts. Interestingly, the postnatal double knockouts displayed hyperinsulinaemia, as shown by inappropriate plasma insulin levels, given their degree of hypoglycaemia. The single knockout mice also showed hyperinsulinaemia and had 31% lower plasma glucose than the wild-types. While the double knockouts did not survive more than 24 h after birth, the single knockouts reached adulthood and their hypoglycaemia continued. Therefore, APP and APLP2 expression modulates plasma insulin and glucose concentrations. Plasma calcium, magnesium and phosphate were also significantly reduced in the double knockouts compared to the wild-types, and they showed distinctive growth restriction, suggesting the involvement of a metabolic impairment. These results link the expression of the APP and APLP2 genes with glucose homeostasis and growth and therefore identify a novel function for the APP family. Copyright (c) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393365     DOI: 10.1002/path.2343

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  24 in total

Review 1.  Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.

Authors:  Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Amyloid precursor protein in pancreatic islets.

Authors:  Joshua A Kulas; Kendra L Puig; Colin K Combs
Journal:  J Endocrinol       Date:  2017-07-14       Impact factor: 4.286

Review 3.  Platelets and Alzheimer's disease: Potential of APP as a biomarker.

Authors:  Geneviève Evin; Qiao-Xin Li
Journal:  World J Psychiatry       Date:  2012-12-22

4.  Integrative analysis of a cross-loci regulation network identifies App as a gene regulating insulin secretion from pancreatic islets.

Authors:  Zhidong Tu; Mark P Keller; Chunsheng Zhang; Mary E Rabaglia; Danielle M Greenawalt; Xia Yang; I-Ming Wang; Hongyue Dai; Matthew D Bruss; Pek Y Lum; Yun-Ping Zhou; Daniel M Kemp; Christina Kendziorski; Brian S Yandell; Alan D Attie; Eric E Schadt; Jun Zhu
Journal:  PLoS Genet       Date:  2012-12-06       Impact factor: 5.917

5.  Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues.

Authors:  Joshua A Kulas; Whitney F Franklin; Nicholas A Smith; Gunjan D Manocha; Kendra L Puig; Kumi Nagamoto-Combs; Rachel D Hendrix; Giulio Taglialatela; Steven W Barger; Colin K Combs
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-11-13       Impact factor: 4.310

Review 6.  APP physiological and pathophysiological functions: insights from animal models.

Authors:  Qinxi Guo; Zilai Wang; Hongmei Li; Mary Wiese; Hui Zheng
Journal:  Cell Res       Date:  2011-07-19       Impact factor: 25.617

7.  Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases.

Authors:  Kristin T Jacobsen; Linda Adlerz; Gerd Multhaup; Kerstin Iverfeldt
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

Review 8.  Amyloid precursor protein and its homologues: a family of proteolysis-dependent receptors.

Authors:  Kristin T Jacobsen; Kerstin Iverfeldt
Journal:  Cell Mol Life Sci       Date:  2009-03-31       Impact factor: 9.261

9.  Analysis of Motor Function in Amyloid Precursor-Like Protein 2 Knockout Mice: The Effects of Ageing and Sex.

Authors:  Phan H Truong; Giuseppe D Ciccotosto; Roberto Cappai
Journal:  Neurochem Res       Date:  2018-10-25       Impact factor: 3.996

10.  Brain-Wide Insulin Resistance, Tau Phosphorylation Changes, and Hippocampal Neprilysin and Amyloid-β Alterations in a Monkey Model of Type 1 Diabetes.

Authors:  Jose Morales-Corraliza; Harrison Wong; Matthew J Mazzella; Shaoli Che; Sang Han Lee; Eva Petkova; Janice D Wagner; Scott E Hemby; Stephen D Ginsberg; Paul M Mathews
Journal:  J Neurosci       Date:  2016-04-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.